For consumers and clinicians the difference between “FDA-cleared,” “FDA-registered,” and general wellness products is not always obvious. Clear communication about intended use and supporting evidence is essential for maintaining trust.
Providers that embrace benchmarks from outside of healthcare and move toward improved non-clinical spend management will unlock the resilience, innovation, and possibilities needed to stay strong in the years ahead.
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
Industry leaders say the No Surprises Act is protecting patients from surprise bills, but its Independent Dispute Resolution system is being overused and exploited, driving up costs and prompting calls for reform.
Experts are split on whether H.R. 1 Medicaid changes in 2027 will roll out gradually or on schedule.
Rising healthcare costs are a key focus for AHIP, whose CEO says the group is pushing reforms to boost competition and reduce administrative burden.
The specialty access and capacity crisis demands more than incremental fixes. It requires expanding virtual access and fundamentally rethinking how specialty care can be delivered.
How to turn analytics into actual policy outcomes.
In a recent letter, Senate Democrats proposed lowering healthcare costs, expanding coverage and cracking down on insurance company practices.
An NYU Stern report links private equity in healthcare to worse outcomes and higher bankruptcy risk, calling for reforms and stronger oversight.
Leaders must resist the urge to replicate urban models that do not translate well to rural contexts. Instead, they should design solutions that are built for rural communities, grounded in local insight and enabled by scalable capabilities.
If CMS and private payers are serious about whole-person health, reimbursement structures must align with the workforce actually delivering that care. Payment pathways should recognize the value of the broader care team and enable the seamless integration of their expertise with the objective data generated through connected devices and programs like RPM.
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
GuardDog Telehealth admitted it misrepresented its services to access patients’ health information, marking the first major concession in Epic’s lawsuit against Health Gorilla and other defendants accused of exploiting interoperability networks. The broader case is still ongoing.
Employer groups praised a bill aimed at boosting healthcare competition and lowering costs by banning anticompetitive insurer-provider contracts.
Every life sciences organization needs to consider how best to apply machine learning (ML) to RWE to support better patient outcomes. Here’s how they can ensure RWE is “ML-ready.”
Congress has already granted the FDA flexibility in evaluating therapies for rare diseases, including the use of real-world evidence and natural history data when traditional large-scale trials are not feasible. The question before the FDA now is not if those tools can be applied – they can – but if the agency has the courage to use them before more patients lose their autonomy, and ultimately, their lives, to rare disease.
In the latest episode of the Debunked Podcast, the discussion revolved around the Break Up Big Medicine legislation to rein in healthcare giants and ways to introduce meaningful PBM reform.